CDKN2B Antikörper (C-Term)
Kurzübersicht für CDKN2B Antikörper (C-Term) (ABIN6735853)
Target
Alle CDKN2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Human CDKN2B / p15 INK4b
-
Homologie
- Percent identity by BLAST analysis: Pig (100%) Dog, Rabbit (91%) Mouse, Rat, Guinea pig (83%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human CDKN2B (P42772, NP_004927). Percent identity by BLAST analysis: Human, Chimpanzee, Gibbon, Monkey, Elephant, Bovine, Rabbit, Pig (100%), Gorilla, Marmoset, Panda, Dog, Horse, Guinea pig (91%), Bat (90%), Mouse, Rat (83%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: WB (0.2 - 1 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Andere Bezeichnung
- CDKN2B / p15 INK4b
-
Hintergrund
-
Name/Gene ID: CDKN2B
Synonyms: CDKN2B, CDK inhibitory protein, CDK4B inhibitor, INK4B, MTS2, Multiple tumor suppressor 2, p14_INK4B, p15, p14_CDK inhibitor, p15 CDK inhibitor, p15 INK4b, p15-INK4b, p15_INK4B, p14-INK4b, p15INK4b, CDK4I, MTS-2, TP15 -
Gen-ID
- 1030
-
NCBI Accession
- NP_004927
-
UniProt
- P42772
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-